期刊文献+

扩张型心肌病合并左心室血栓的超声心动图分析 被引量:2

Echocardiographic characters of left ventricular thrombus in patients with dilated cardiomyopathy
下载PDF
导出
摘要 目的探讨扩张型心肌病(DCM)患者合并左心室附壁血栓的超声心动图特征。方法回顾性分析188例DCM患者超声心动图资料,根据左心室有无血栓形成分为无血栓组和有血栓组,对两组患者的超声心动图检查结果进行比较。结果血栓组共18例(9.6%),与无血栓组相比,该组患者左心室射血分数(LVEF)及左心室短轴缩短率(LVFS)较低,(28.9±9.8)%vs(36.4±6.6)%(、11.3±3.3)%vs(17.1±5.2)%,左心房内径(LAD)及左心室收缩末期内径(LVIDs)较大,(48.6±4.1)mm vs(43.2±5.1)mm、(61.7±4.7)mm vs(51.8±5.3)mm;中重度二尖瓣反流(MR)发生率较低(22.2%vs 70.5%,均P<0.01)。结论 DCM患者LAD及LVIDs较大、左心室心肌收缩力下降明显者易导致左心室附壁血栓形成;二尖瓣中重度MR有对抗左心室血栓形成的作用。 Objective To investigate the echocardiographic characters of left ventricular thrombus in patients with dilated cardiomyopathy(DCM).Methods We analyzed the data of 188 patients with DCM.The patients were divided into two groups:patients with left ventricle thrombus group and patients without left ventricle thrombus group.We sought to compare the transthoracic echocardiographic outcome of these two groups.Results We identified 18 patients(9.6%) with left ventricle thrombus.There were significant statistical difference in some factors between two groups,such as left ventricle ejection fraction(28.9±9.8)% vs(36.4±6.6)%,fractional shortening(11.3±3.3)% vs(17.1±5.2)%,internal diameter of systolic left ventricle(61.7±4.7)mm vs(51.8±5.3) mm,and left atrium(48.6±4.1) mm vs(43.2±5.1) mm(P0.01).Moderate-severe mitral valve regurgitation(22.2% vs 70.5%)more frequently occurred among patients without left ventricle thrombus(P0.01).Conclusion Our findings suggest that some factors may indicate a higher risk of thrombus formation,such as the left ventricular systolic disfunction,enlargement of internal diameter of systolic left ventricle and left atrium.Moderate-severe mitral valve regurgitation may prevent mural thrombus formation within the left ventricle.
出处 《临床荟萃》 CAS 2011年第4期296-297,300,F0002,共4页 Clinical Focus
关键词 心肌病 扩张型 血栓形成 心室 超声心动描记术 cardiomyopathy dilated thrombosis heart ventricle echocardiography
  • 相关文献

参考文献8

  • 1Maron B J, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee;Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups: and Council on Epidemiology and Prevention [J]. Circulation, 2006,113(14) : 1807-1816.
  • 2Solheim S, Seljeflot I, Lunde K, et al. Frequency of left ventricular thrombus in patients with anterior wall acute myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy [J]. Am J Cardiol, 2010,106(9) : 1197-1200.
  • 3Jefferies JL, Towbin JA. Dilated cardiomyopathy[J]. Lancet, 2010,375(9716) :752-762.
  • 4叶任高.内科学[M]5版[M].北京:人民卫生出版社,2002.862.
  • 5Abdo AS, Kemp R, Barham J, et al. Dilated cardiomyopathy and role of antithrombotic therapy[J]. Am J Med Sci, 2010, 339(6):557- 560.
  • 6Ozdemir N, Kaymaz C, Daglar E, et al. Severe mitral regurgitation may prevent mural thrombus formation within the left ventricle with systolic dysfunction[J]. Jpn Heart J, 2002,43(5) :495- 503.
  • 7Aleksova A, Sabbadini G, Merlo M, et al. Natural history of dilated eardiomyopathy: from asymptomatie left ventricular dysfunction to heart failure-a subgroup analysis from the Trieste Cardiomyopathy Registry [J].J Cardiovasc Med (Hagerstown) ,2009,10(9) :699-705.
  • 8施仲伟.超声心动图在心血管疾病诊断中的应用[J].临床荟萃,2009,24(19):1671-1674. 被引量:5

二级参考文献15

  • 1Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echoeardiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography) [DB/OL]. 2003. Available at: www. acc. org/qualityandscience/clinical/guidelines/echo/index _ clean. pdf.
  • 2Abraham TP,Dimaano VL, Liang HY. Role of tissue Doppler and strain eehocardiography in current clinical practicer [J]. Circulation, 2007,116(22) : 2597-2609.
  • 3Ho CY, Solomon SD. A clinician's guide to tissue Doppler imaging[J]. Circulation,2006,113(10) ;e396- 398.
  • 4Mullens W,Tang WH, Grimm RA. Using echocardiography in cardiac resynchronization therapy[J]. Am Heart J, 2007, 154 (6) :1011-1020.
  • 5Chung ES,Leon AR,Tavazzi L,et al. Results of the predictors of response to CRT (PROSPECT) trial[J]. Circulation, 2008, 117(20) : 2608-2616.
  • 6Marwick TH. Hype and hope in the use of eehocardiography for selection for cardiac resynchronization therapy: the Tower of Babel revisited[J]. Circulation,2008,117(20):2573-2576.
  • 7Main ML, Goldman JH, Grayburn PA. Thinking outside the "box": the ultrasound contrast controversy[J]. J Am Coll Cardiol,2007,50(25) :2434-2437.
  • 8Main ML, Ryan AC, Davis TE, et al. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4,300,966 consecutive patients)[J]. Am J Cardiol, 2008,102(12) .1742-1746.
  • 9Dolan MS, Gala SS, Dodla S, et al. Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography. A multicenter experience[J]. J Am Coll Cardiol,2009,53(1) :32-38.
  • 10Sicari R, Nihoyannopoulos P, Evangelista A, et al. Stress echocardiography expert consensus statement : European Association of Echocardiography (EAE) (a registered branch of the ESC)[J]. Eur J Echocardiogr,2008,9(4) ,415-437.

共引文献273

同被引文献30

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部